Advanced company searchLink opens in new window

TETRIS PHARMA LTD

Company number 12548259

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
11 Sep 2024 AA Full accounts made up to 31 December 2023
18 Jul 2024 AP01 Appointment of Dr Jan Jezek as a director on 17 July 2024
18 Jul 2024 TM01 Termination of appointment of Susan Day Lowther as a director on 17 July 2024
29 Apr 2024 CS01 Confirmation statement made on 29 April 2024 with updates
04 Oct 2023 TM01 Termination of appointment of Shafiq Mohammed Choudhary as a director on 22 September 2023
17 Jul 2023 AA Full accounts made up to 31 December 2022
23 May 2023 CS01 Confirmation statement made on 15 May 2023 with updates
15 Dec 2022 MR04 Satisfaction of charge 125482590001 in full
15 Nov 2022 AA01 Current accounting period shortened from 30 April 2023 to 31 December 2022
01 Nov 2022 AA Total exemption full accounts made up to 30 April 2022
01 Sep 2022 SH01 Statement of capital following an allotment of shares on 31 July 2022
  • GBP 1,214,983.00
01 Sep 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
22 Aug 2022 MA Memorandum and Articles of Association
18 Aug 2022 AP01 Appointment of Dr. Sarah Jennifer Howell as a director on 4 August 2022
11 Aug 2022 PSC02 Notification of Arecor Therapeutics Plc as a person with significant control on 4 August 2022
11 Aug 2022 PSC09 Withdrawal of a person with significant control statement on 11 August 2022
10 Aug 2022 AP01 Appointment of Susan Day Lowther as a director on 4 August 2022
10 Aug 2022 TM01 Termination of appointment of Madeleine Elizabeth Kennedy as a director on 4 August 2022
10 Aug 2022 TM01 Termination of appointment of John Leslie Galloway as a director on 4 August 2022
09 Aug 2022 RP04SH01 Second filing of a statement of capital following an allotment of shares on 25 July 2022
  • GBP 540
27 Jul 2022 SH01 Statement of capital following an allotment of shares on 21 July 2022
  • GBP 540
  • ANNOTATION Clarification a second filed SH01 was registered on 09.08.2022.
27 Jul 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
18 Jul 2022 SH19 Statement of capital on 18 July 2022
  • GBP 510
18 Jul 2022 OC138 Reduction of iss capital and minute (oc)
18 Jul 2022 CERT16 Certificate of reduction of issued capital and share premium